Back to Search
Start Over
Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action.
- Source :
-
Molecular neurobiology [Mol Neurobiol] 2018 Jul; Vol. 55 (7), pp. 5490-5504. Date of Electronic Publication: 2017 Sep 30. - Publication Year :
- 2018
-
Abstract
- Glioblastoma multiforme is the most common and lethal malignant brain tumor. Because of its complexity and heterogeneity, this tumor has become resistant to conventional therapies and the available treatment produces multiple side effects. Here, using multiple experimental approaches, we demonstrate that three mastoparan peptides-Polybia-MP1, Mastoparan X, and HR1-from solitary wasp venom exhibit potent anticancer activity toward human glioblastoma multiforme cells. Importantly, the antiglioblastoma action of mastoparan peptides occurs by membranolytic activity, leading to necrosis. Our data also suggest a direct relation between mastoparan membranolytic potency and the presence of negatively charged phospholipids like phosphatidylserine. Collectively, these data may warrant additional studies for mastoparan peptides as new agents for the treatment of glioblastoma multiforme brain tumor.
- Subjects :
- Amino Acid Sequence
Calcium metabolism
Cations
Cell Line, Tumor
Cell Nucleus drug effects
Cell Nucleus metabolism
Cell Shape drug effects
Cell Survival drug effects
Glioblastoma pathology
Glioblastoma ultrastructure
Humans
Intercellular Signaling Peptides and Proteins
Membrane Potential, Mitochondrial drug effects
Necrosis
Peptides chemistry
Peptides pharmacology
Protein Structure, Secondary
Wasp Venoms chemistry
Wasp Venoms pharmacology
Cell Membrane pathology
Glioblastoma drug therapy
Peptides therapeutic use
Wasp Venoms therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1559-1182
- Volume :
- 55
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Molecular neurobiology
- Publication Type :
- Academic Journal
- Accession number :
- 28965321
- Full Text :
- https://doi.org/10.1007/s12035-017-0782-1